Oncopeptides completes patient enrollment in phase 2 PORT study

Press/Media

Period5 May 2021

Media coverage

1

Media coverage

  • TitleOncopeptides completes patient enrollment in phase 2 PORT study
    Media name/outletCision Nordic Companies Press Releases (Scandinavia)
    Country/TerritoryDenmark
    Date5/05/21
    PersonsJoshua Richter